Skip to main content
Log in

Myelofibrosis as the initial presentation of donor-derived myelodysplastic syndrome/AML: failure of a lasting response to a second allogeneic transplant from the original donor

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  1. Tamaki H, Matsuoka M . Donor-derived T-cell leukemia after bone marrow transplantation. N Engl J Med 2006; 354: 1758–1759.

    Article  CAS  PubMed  Google Scholar 

  2. Pieroni F, Oliveira FM, Panepucci RA, Voltarelli JC, Simoes BP, Falcao RP . Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia. Bone Marrow Transplant 2006; 37: 801–802.

    Article  CAS  PubMed  Google Scholar 

  3. Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S et al. Development of leukemia in donor cells after allogeneic stem cell transplantation—a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2005; 90: 969–975.

    PubMed  Google Scholar 

  4. Fraser CJ, Hirsch BA, Dayton V, Creer MH, Neglia JP, Wagner JE et al. First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation. Blood 2005; 106: 4377–4380.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bauermeister DE . Quantitation of bone marrow reticulin—a normal range. Am J Clin Pathol 1971; 56: 24–31.

    Article  CAS  PubMed  Google Scholar 

  6. Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der WJ, Orazi A . European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005; 90: 1128–1132.

    PubMed  Google Scholar 

  7. Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007; 110: 1092–1097.

    Article  CAS  PubMed  Google Scholar 

  8. Rizzi R, Pastore D, Liso A, Liuzzi GM, Dalena AM, Specchia G et al. Autoimmune myelofibrosis: report of three cases and review of the literature. Leuk Lymphoma 2004; 45: 561–566.

    Article  PubMed  Google Scholar 

  9. Reilly JT . Idiopathic myelofibrosis: pathogenesis to treatment. Hematol Oncol 2006; 24: 56–63.

    Article  CAS  PubMed  Google Scholar 

  10. Ho AY, Pagliuca A, Kenyon M, Parker JE, Mijovic A, Devereux S et al. Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning. Blood 2004; 104: 1616–1623.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Professor HJ Deeg, Fred Hutchinson Cancer Centre, Seattle for his helpful discussions regarding this patient.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R J Cutting.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cutting, R., Welch, E., Channer, J. et al. Myelofibrosis as the initial presentation of donor-derived myelodysplastic syndrome/AML: failure of a lasting response to a second allogeneic transplant from the original donor. Bone Marrow Transplant 42, 631–633 (2008). https://doi.org/10.1038/bmt.2008.224

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.224

  • Springer Nature Limited

This article is cited by

Navigation